TCRT ALAUNOS THERAPEUTICS INC Capital Structure Changes 8-K Filing 2025 - Equity Offerings On May 19, 2025, Alaunos Therapeutics, Inc. entered into an agreement with Mast Hill Fund to sell up to $25 million in common stock, enabling sales over the next 24 months at the company's discretion. The agreement includes a warrant for 79,900 shares at an exercise price of $4.00.Get access to all SEC 8-K filings of the ALAUNOS THERAPEUTICS INC